Literature DB >> 21752617

Systemic responses during local viral infections: type I IFNs sound the alarm.

Carolina B López1, Tamar Hermesh.   

Abstract

Type I IFNs are well known for their role in controlling virus replication and spread. Type I IFNs produced by the infected tissue also signal beyond the boundaries of the infection to regulate different elements of the anti-viral immune response. Recent reports show that type I IFNs directly condition naive monocytes residing in the distal bone marrow (BM) and induce the expression of effector molecules in memory T cells, before their recruitment to the infected site. In addition, hematopoietic stem cells (HSCs) were shown to enter the cell cycle in response to systemically distributed type I IFNs. These discoveries expand our understanding of the pleiotropic effects of type I IFNs during infection and highlight the critical role of systemic signals in the development of an effective response to a localized viral infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752617      PMCID: PMC3163724          DOI: 10.1016/j.coi.2011.06.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  51 in total

1.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Induction of bystander T cell proliferation by viruses and type I interferon in vivo.

Authors:  D F Tough; P Borrow; J Sprent
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

Review 3.  Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.

Authors:  Kai Hübel; David C Dale; W Conrad Liles
Journal:  J Infect Dis       Date:  2002-04-19       Impact factor: 5.226

Review 4.  Circulating cytokines as mediators of fever.

Authors:  M G Netea; B J Kullberg; J W Van der Meer
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

5.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.

Authors:  F G Hayden; R Fritz; M C Lobo; W Alvord; W Strober; S E Straus
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Cascade of fever production in mice infected with influenza virus.

Authors:  M Kurokawa; M Imakita; C A Kumeda; K Shiraki
Journal:  J Med Virol       Date:  1996-10       Impact factor: 2.327

7.  Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation.

Authors:  Sunanda Basu; George Hodgson; Melissa Katz; Ashley R Dunn
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

8.  Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.

Authors:  Lisa M Sedger; Sam Hou; Sarah R Osvath; Moira B Glaccum; Jacques J Peschon; Nico van Rooijen; Lisa Hyland
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

9.  A kinetic study of immune mediators in the lungs of mice infected with influenza A virus.

Authors:  T Hennet; H J Ziltener; K Frei; E Peterhans
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

10.  Cytokines and the acute phase response to influenza virus in mice.

Authors:  C A Conn; J L McClellan; H F Maassab; C W Smitka; J A Majde; M J Kluger
Journal:  Am J Physiol       Date:  1995-01
View more
  19 in total

1.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

Review 2.  The impact of infection and tissue damage in solid-organ transplantation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

3.  Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.

Authors:  Jaime L Wetzel; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

4.  Expression of biologically active human interferon alpha 2 in Aloe vera.

Authors:  William Lowther; Kevin Lorick; Susan D Lawrence; Wen-Shuz Yeow
Journal:  Transgenic Res       Date:  2012-04-24       Impact factor: 2.788

5.  Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation.

Authors:  Elizabeth E Waffarn; Christine J Hastey; Neha Dixit; Youn Soo Choi; Simon Cherry; Ulrich Kalinke; Scott I Simon; Nicole Baumgarth
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

6.  Interferon-induced protein Ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus.

Authors:  Volker Fensterl; Jaime L Wetzel; Ganes C Sen
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

Review 7.  Infection-induced changes in hematopoiesis.

Authors:  Arielle Glatman Zaretsky; Julie B Engiles; Christopher A Hunter
Journal:  J Immunol       Date:  2014-01-01       Impact factor: 5.422

Review 8.  The innate immune response to RSV: Advances in our understanding of critical viral and host factors.

Authors:  Yan Sun; Carolina B López
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

Review 9.  Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine       Date:  2013-06-10       Impact factor: 3.861

10.  Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Authors:  Yongzhi Chen; Xuqiu Lei; Zhaozhao Jiang; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.